6,458
Participants
Start Date
April 11, 2023
Primary Completion Date
May 8, 2025
Study Completion Date
May 8, 2025
Sugammadex
As this is a non-interventional study designed to collect data as part of routine clinical practice, the type and dose of neuromuscular blocking agents are all based on the clinician's judgment.
Korea University Anam Hospital, Seoul
Lead Sponsor
Boryung Pharmaceutical Co., Ltd
INDUSTRY